Abstract
The phospholipid composition and fatty acid profiles of human eosinophils were studied. Extremely high levels of ether phospholipids were found in this type of cell, such as alkylacylglycerophosphocholine (GPC) and alkenyl-acylglycerophosphoethanolamine (GPE); these two ether phospholipids accounted for about three-fourths of the choline and ethanolamine glycerophospholipids (CGP and EGP), respectively. Fatty acid analyses revealed that very large portions of arachidonic acid (20∶4) were esterified to alkylacyl-GPC (92.0% in CGP) and alkenylacyl-GPE (86.6% in EGP), respectively. While high amounts of alkylacyl-GPC and the abundance of 20∶4 in this ether phospholipid have been observed in other types of blood cells of various animals, these percentages for human eosinophils are the highest among such cells. These results suggest that alkyl and alkenyl ether phospholipids play essential roles in human eosinophils in various physiological and pathological conditions.
Similar content being viewed by others
Abbreviations
- CGP:
-
choline glycerophospholipids
- ECF-A:
-
eosinophil chemotactic factor of anaphylaxis
- EDTA:
-
ethylenediamine tetraacetic acid
- EGP:
-
ethanolamine glycerophospholipids
- FMLP:
-
formylmethionylleucylphenylalanine
- GPC:
-
glycerophosphocholine
- PAF:
-
platelet-activating factor
- GLC:
-
gas liquid chromatography
- TLC:
-
thin layer chromatography
References
Mahmoud, A.A.F., Warren, K.S., and Peters, P.A. (1975)J. Exp. Med. 142, 805–813.
Vadas, M.A., David, J.R., Butterworth, A.E., Pisani, N.T., and Siongok, T.A. (1979)J. Immunol. 122, 1228–1236.
Butterworth, A.E., and David, J.R. (1981)N. Engl. J. Med. 304, 154–156.
Lowell, F.C. (1967)J. Am. Med. Assoc. 202, 875–878.
Franklin, W. (1974)N. Engl. J. Med. 290, 1469–1472.
Guputa, S., Frenkel, R., Rosenstein, M., and Grieco, M.H. (1975)Clin. Exp. Immunol. 22, 438–445.
Horn, B.R., Robin, E.D., Theodore, J., and Van Kessel, A. (1975)N. Engl. J. Med. 292, 1152–1155.
Butterworth, A.E., Wassom, D.L., Gleich, G.J., Loegering, D.A., and David, J.R. (1979)J. Immunol. 122, 221–229.
Frigas, E., Loegering, D.A., and Gleich, G.J. (1980)Lab. Invest. 42, 35–43.
Lee, T-C., Lenihan, D.J., Malone, B., Roddy, L.L., and Wasserman, S.I. (1984)J. Biol. Chem. 259, 5526–530.
Elsas, P., Lee, T.H., Lenzi, H.L., and Dessein, A.J. (1987)Ann. Inst. Pasteur Immunol. 138, 97–116.
Taniguchi, N., Mita, H., Saito, H., Yui, Y., Kajita, T., and Shida, T. (1985)Allergy 40, 571–573.
Bruynzeel, P.L., Kok, P.T., Hamelink, M.L., Kijne, A.M., and Verhagen, J. (1985)FEBS Lett. 189, 350–354.
Wardlaw, A.J., Moqbel, R., Cromwell, O., and Kay, A.B. (1986)J. Clin. Invest. 78, 1701–1706.
Page, C.P., Archer, C.B., Paul, W., and Morley, J. (1984)Trends Pharmacol. Sci. 5, 239–241.
Gärtner, I. (1980)Immunology 40, 133–136.
Bligh, E.G., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Sugiura, T., Nakajima, M., Sekiguchi, N., Nakagawa, Y., and Waku, K. (1983)Lipids 18, 125–129.
Rouser, G., Siakotos, A.N., and Fleischer, S. (1966)Lipids 1, 85–86.
Mueller, H.W., O'Flaberty, J.T., Greene, D.G., Samuel, M.P., and Wykle, R.L. (1984)J. Lipid Res. 25, 383–388.
Sugiura, T., and Waku, K. (1987) inPlatelet-Activating Factor and Related Lipid Mediators (Snyder, F., ed.) pp. 55–85, Plenum Press, New York.
Albert, D.H., and Snyder, F. (1983)J. Biol. Chem. 258, 97–102.
Sugiura, T., Katayama, O., Fukui, J., Nakagawa, Y., and Waku, K. (1984)FEBS Lett. 165, 273–276.
Nakagawa, Y., Kurihara, K., Sugiura, T., and Waku, K. (1986)Biochim. Biophys. Acta 876, 601–610.
Swendsen, C.L., Ellis, J.M., Chilton, F.H., O'Flaherty, J.T., and Wykle, R.L. (1983)Biochem. Biophys. Res. Commun. 113, 72–79.
Albert, D.H., and Snyder, F. (1984)Biochim. Biophys. Acta 796, 92–101.
Billah, M.M., Bryant, R.W., and Siegel, M.I. (1985)J. Biol. Chem. 260, 6899–6906.
Author information
Authors and Affiliations
About this article
Cite this article
Ojima-Uchiyama, A., Masuzawa, Y., Sugiura, T. et al. Phospholipid analysis of human eosinophils: High levels of alkylacylglycerophosphocholine (PAF precursor). Lipids 23, 815–817 (1988). https://doi.org/10.1007/BF02536227
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536227